Mergers & AcquisitionsMedium•25 October 2026•
1 min read
Challenger Board Rejects $11.80 Per Share Takeover Bid from Dai-ichi Life
Key Facts
1Challenger's board rejected a takeover bid from its largest shareholder, TAL Daiichi Life, valued at $11.80 per share.
2The board intends to engage with the Japanese insurance giant to see if a recommendable proposal can be reached.
Challenger's board rejected a takeover bid from its largest shareholder, TAL Daiichi Life, valued at $11.80 per share. Capital Brief reported that the board concluded the offer was insufficient to recommend to shareholders at its current level.
The board intends to engage with the Japanese insurance giant to determine if a recommendable proposal can be reached. Challenger shares had recently closed at $11.92, a level exceeding the rejected offer price as the company seeks a valuation that better reflects its position.